Immunic (IMUX) Change in Acquisitions & Divestments (2013 - 2023)
Immunic's (IMUX) quarterly Change in Acquisitions & Divestments came in at $4.4 million in Q2 2023, down 19.89% quarter-over-quarter from $5.4 million in Q1 2023.
Immunic (IMUX) Change in Acquisitions & Divestments (2013 - 2023) Analysis & Trends
Immunic has disclosed Change in Acquisitions & Divestments across 2 years of filings, most recently posting $4.4 million for Q2 2023.
- Change in Acquisitions & Divestments for Q2 2023 came in at $4.4 million, changed N/A year-over-year; the trailing twelve-month figure through Jun 2023 was $9.8 million (up 95.88% YoY), and the FY2013 annual result was $17.0 million, changed N/A from the prior year.
- Change in Acquisitions & Divestments came in at $4.4 million for Q2 2023 at Immunic, down from $5.4 million in the prior quarter.
- In the past five years, Change in Acquisitions & Divestments ranged from a high of $5.4 million in Q1 2023 to a low of $4.4 million in Q2 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 723,416.35 Bn | 723,416.32 Bn | - |
| 2 | Belite Bio | 57,340.00 Bn | 57,340.00 Bn | - |
| 3 | Quantum Biopharma | 19,125.08 Bn | 19,125.08 Bn | - |
| 4 | Legend Biotech | 3,262.00 Bn | 3,261.71 Bn | 242.10 Mn |
| 5 | Akari Therapeutics | 1,789.67 Bn | 1,789.67 Bn | - |
| 6 | Evaxion A | 1,480.39 Bn | 1,480.37 Bn | - |
| 7 | Psyence Biomedical | 241.78 Bn | 241.78 Bn | - |
| 8 | Vertex Pharmaceuticals | 113.54 Bn | 106.29 Bn | 2.59 Bn |
| 9 | Abivax | 94.26 Bn | 94.26 Bn | - |
| 10 | Immunic | 384.84 Mn | 198.21 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2023 | 4.36 Mn |
| Jun 30, 2023 | 4.36 Mn |
| Mar 31, 2023 | 5.44 Mn |
| Mar 31, 2023 | 5.44 Mn |
| Sep 30, 2013 | 5.00 Mn |
| Sep 30, 2013 | 5.00 Mn |
| Jun 30, 2013 | 7.00 Mn |
| Jun 30, 2013 | 7.00 Mn |
| Mar 31, 2013 | 5.00 Mn |
| Mar 31, 2013 | 5.00 Mn |